Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label extension of bosentan in pulmonary hypertension associated with sickle cell disease (ASSET extension)
2006-000374-75Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Dec 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of bosentan in pulmonary hypertension associated with sickle cell disease (PH-SCD) and pulmonary hypertension (PH), sponsored by Actelion Pharmaceuticals Ltd. Started Dec 2006; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary hypertension associated with sickle cell disease (PH-SCD)pulmonary hypertension (PH)
Beyond the preview
Go deeper on 2006-000374-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000374-75.